Octavius Pharma has developed DC granules of Vildagliptin for making Vildagliptin tablets. Product has been developed to ensure proper Dissolution profile throughout shelf life. Finished tablets specifications and dissolution profile complies as per IH specification.
| Strength | 50 / 100 mg |
| Finished Dosage Form | Tablets |
| Finished Product Compliance | IH |
| API DMF | Available |
| CTD Dosssier | Under Development |
Vildagliptin: Vildagliptin is a potent and selective DPP-4 inhibitor that enhances pancreatic islet function, improves insulin secretion, and reduces inappropriate glucagon secretion in patients with type 2 diabetes, leading to better glycemic control without weight gain and minimal hypoglycemia.
GET IN TOUCH
For inquiries and collaboration opportunities, reach out to us today! Your gateway to innovative healthcare solutions awaits!
"*" indicates required fields